Tower View Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-117
Closed -$9K 179
2023
Q2
$9K Buy
+117
New +$9.06K 0.01% 122
2022
Q3
Sell
-50
Closed -$4K 165
2022
Q2
$4K Hold
50
﹤0.01% 140
2022
Q1
$4K Hold
50
﹤0.01% 168
2021
Q4
$4K Hold
50
﹤0.01% 174
2021
Q3
$4K Buy
+50
New +$3.97K ﹤0.01% 205
2021
Q2
Sell
-75
Closed -$6K 175
2021
Q1
$6K Buy
+75
New +$5.88K ﹤0.01% 154
2019
Q4
Sell
-40
Closed -$3K 141
2019
Q3
$3K Hold
40
﹤0.01% 125
2019
Q2
$3K Hold
40
﹤0.01% 122
2019
Q1
$3K Hold
40
﹤0.01% 127
2018
Q4
$2K Buy
40
+1
+3% +$63 ﹤0.01% 129
2018
Q3
$3K Hold
39
﹤0.01% 146
2018
Q2
$3K Hold
39
﹤0.01% 135
2018
Q1
$3K Hold
39
﹤0.01% 129
2017
Q4
$3K Buy
+39
New +$2.85K ﹤0.01% 134

Other funds holding CL

Tower View Wealth Management's CL Position: Q3 2023 in Review

Tower View Wealth Management sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 117 shares — an estimated $9K sold.

Tower View Wealth Management first reported a position in CL in Q4 2017 and held it in 14 quarters. The position peaked at $9K in Q2 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Tower View Wealth Management reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Tower View Wealth Management sold 117 Colgate-Palmolive shares in Q3 2023, an estimated $9K.
  • Tower View Wealth Management first reported a position in Colgate-Palmolive in Q4 2017 and held it in 14 quarters.
  • Tower View Wealth Management's Colgate-Palmolive position peaked at $9K in Q2 2023.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Tower View Wealth Management's 13F filing for Q3 2023, filed 31 Oct 2023.